Coca-Cola's Earnings Beat On Top And Bottom Lines


(MENAFN- Baystreet) Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate

  • Dave & Busters Lets Customers Bet
  • Stellantis Stumbles on Numbers
  • Walmart Launches New Grocery Brand
  • Why Meta Platforms and IBM Sold Off Last Week Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staff - Tuesday, April 30, 2024

    Coca-Cola's Earnings Beat On Top And Bottom Lines

    Coca-Cola (KO) has reported first-quarter financial result that beat Wall Street forecasts on the top and bottom lines due to price increases of its beverages.

    The Atlanta-based company announced earnings per share (EPS) of $0.72 U.S. versus $0.70 U.S. that was expected on Wall Street.

    Revenue in the quarter totaled $11.30 billion U.S. compared to forecasts of $11.01 billion U.S. Sales rose 11% from a year ago.

    Coke attributed the strong results to increased prices on many of its soft drinks. The company also reported that its global unit case volume increased 1% between January and March.

    Looking ahead, Coke said it now expects revenue growth of 8% to 9% this year, up from its previous outlook of 6% to 7% growth.

    The company reiterated its outlook for full-year earnings growth of 4% to 5%.

    For the current second quarter, Coca-Cola expects that its comparable revenue will include a 6% currency headwind and a 5% hit from acquisitions, divestitures, and structural changes.

    The stock of Coca-Cola has declined 4% over the last 12 months to trade at $62.04 U.S. per share.





    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks

    MENAFN30042024000212011056ID1108157157


  • Baystreet.ca

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.